Predictors of Antidepressant Treatment Response: The Emory CIDAR
Latest Information Update: 07 Mar 2025
At a glance
- Drugs Duloxetine (Primary) ; Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms PReDICT
Most Recent Events
- 07 Mar 2025 Results assessing metabolic effects of three randomly-assigned treatments: escitalopram, duloxetine, and Cognitive-Behavioral Therapy (CBT) in 163 treatment-naive outpatients with major depressive disorder, published in the Journal of Affective Disorders.
- 16 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 09 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.